Gas and Light: Triggers of C-di-GMP-mediated Regulation
Overview
Affiliations
The widespread bacterial second messenger c-di-GMP is responsible for regulating many important physiological functions such as biofilm formation, motility, cell differentiation, and virulence. The synthesis and degradation of c-di-GMP in bacterial cells depend, respectively, on diguanylate cyclases and c-di-GMP-specific phosphodiesterases. Since c-di-GMP metabolic enzymes (CMEs) are often fused to sensory domains, their activities are likely controlled by environmental signals, thereby altering cellular c-di-GMP levels and regulating bacterial adaptive behaviors. Previous studies on c-di-GMP-mediated regulation mainly focused on downstream signaling pathways, including the identification of CMEs, cellular c-di-GMP receptors, and c-di-GMP-regulated processes. The mechanisms of CME regulation by upstream signaling modules received less attention, resulting in a limited understanding of the c-di-GMP regulatory networks. We review here the diversity of sensory domains related to bacterial CME regulation. We specifically discuss those domains that are capable of sensing gaseous or light signals and the mechanisms they use for regulating cellular c-di-GMP levels. It is hoped that this review would help refine the complete c-di-GMP regulatory networks and improve our understanding of bacterial behaviors in changing environments. In practical terms, this may eventually provide a way to control c-di-GMP-mediated bacterial biofilm formation and pathogenesis in general.
Specificities of Chemosensory Receptors in the Human Gut Microbiota.
Xu W, Jalomo-Khayrova E, Gumerov V, Ross P, Kobel T, Schindler D bioRxiv. 2025; .
PMID: 39990360 PMC: 11844446. DOI: 10.1101/2025.02.11.637667.
An improved bacterial single-cell RNA-seq reveals biofilm heterogeneity.
Yan X, Liao H, Wang C, Huang C, Zhang W, Guo C Elife. 2024; 13.
PMID: 39689163 PMC: 11651652. DOI: 10.7554/eLife.97543.
Multidrug resistance in Pseudomonas aeruginosa: genetic control mechanisms and therapeutic advances.
Zhao Y, Xu H, Wang H, Wang P, Chen S Mol Biomed. 2024; 5(1):62.
PMID: 39592545 PMC: 11599538. DOI: 10.1186/s43556-024-00221-y.
Heppert J, Awori R, Cao M, Chen G, McLeish J, Goodrich-Blair H BMC Genomics. 2024; 25(1):1087.
PMID: 39548374 PMC: 11566119. DOI: 10.1186/s12864-024-10858-2.
Wu W, Kumar P, Brautigam C, Tso S, Baniasadi H, Kober D Nat Commun. 2024; 15(1):9653.
PMID: 39511182 PMC: 11543664. DOI: 10.1038/s41467-024-53942-7.